VEGFA and age-related macular degeneration: Recent progress has been made beyond standard laser therapy, in the use of VEGF inhibitor bevacizumab, not only in choroidal neovascularization and age-related macular degeneration, but also in the treatment of ROP of stage 3 or higher.